ISSN: 0973-7510

E-ISSN: 2581-690X

Open Access
Babak Asghari1, Hamid Reza Sadeghi2 and Mohammad Jalilian3
1Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
2Department of Medical Physics, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
3Imam Khomeini Hospital, Tehran University of Medical Sciences, Iran.
J Pure Appl Microbiol. 2017;11(2):753-758
https://doi.org/10.22207/JPAM.11.2.14 | © The Author(s). 2017
Received: 30/03/2017 | Accepted: 01/06/2017 | Published: 30/06/2017
Abstract

Vancomycin-resistant enterococci (VRE) remain as one of the important cause of nosocomial infections. Reports of the VRE carriers are increasing worldwide. In this study, a total of 220 patients was screened for vancomycin-resistant enterococci colonization, of which 36 (16.3%) were VRE carriers. Among the VRE isolates, 17 were vanA positive. The distribution of VRE carriers in different wards that pose high risks for healthcare infection to hospitalized patients emphasizes applying suitable infection control strategies to prevent the dissemination of the organism. This is the first report from Iran in which a vanA-containing enterococci were isolated from intestinal colonization of patients. Strict measures are required to control the further spread of VRE strains in the Iranian patients.

Keywords

Vancomycin-resistant enterococci, Antibiotic resistance, Colonization surveillance, Hospital infection control, Patients

Article Metrics

Article View: 1481

Share This Article

© The Author(s) 2017. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.